Guanxinning attenuates diabetic myocardial ischemia-reperfusion injury by targeting oral <i>Fusobacterium nucleatum</i> and modulating PTEN signaling.

Front Pharmacol · 2025 · PMC12223323 · PMID 40612744

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

an increasing trendP > 0.05actually significant

Although an increasing trend in PTEN expression was observed in the GXN-H group compared to the DMIRI group, the difference was not statistically significant ( P > 0.05; Figure 5 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Guanxinning attenuates diabetic myocardial ischemia-reperfusion injury by targeting oral &lt;i&gt;Fusobacterium nucleatum&lt;/i&gt; and modulating PTEN signaling.

The sentences

Guanxinning attenuates diabetic myocardial ischemia-reperfusion injury by targeting oral <i>Fusobacterium nucleatum</i> and modulating PTEN signaling.